Consistent with previous publications,30,31,34 hepatocyte ATF4 ablation inhibited hepatic steatosis, reinforcing the notion that hepatic steatosis per se is not damaging and does not increase cancer risk unless it is accompanied by liver damage. This evidence concerns the gene ATF4 and fatty liver disease.